(Q28166857)
Statements
Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD (English)
0 references
20 January 2004
0 references
109
0 references
2
0 references
e9004-5
0 references